Publication:
Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand (PharmacoEconomics, (2019), 37, 2, (267-278), 10.1007/s40273-018-0736-0)

1

Issued Date

2019-02-13

Resource Type

Erratum

ISSN

11792027
11707690

DOI

10.1007/s40273-018-0754-y

Other identifier(s)

2-s2.0-85060121046

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

PharmacoEconomics. Vol.37, No.2 (2019), 291

Suggested Citation

Bunchai Chongmelaxme, Pochamana Phisalprapa, Ratree Manthaisong, Piyameth Dilokthornsakul, Nathorn Chaiyakunapruk Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand (PharmacoEconomics, (2019), 37, 2, (267-278), 10.1007/s40273-018-0736-0). PharmacoEconomics. Vol.37, No.2 (2019), 291. doi:10.1007/s40273-018-0754-y Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/51869

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand (PharmacoEconomics, (2019), 37, 2, (267-278), 10.1007/s40273-018-0736-0)

Author(s)

Bunchai Chongmelaxme
 Pochamana Phisalprapa
 Ratree Manthaisong
 Piyameth Dilokthornsakul
 Nathorn Chaiyakunapruk

Other Contributor(s)

Naresuan University
 Monash University Malaysia
 Faculty of Medicine, Siriraj Hospital, Mahidol University
 Mahasarakham University
 University of Wisconsin

Abstract

© 2018, Springer Nature Switzerland AG. Weight Reduction is Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/123456789/51869

Collections

Scopus 2019